Prevalence of cutaneous manifestations in COVID‐19: A meta‐analysis

Li, Jingmin; Wen, Weijing; Mu, Zhenzhen; Du, Xinying; Han, Xiuping

doi:10.1111/1346-8138.16672

Cited by 6 publications

(3 citation statements)

References 68 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While there are several studies that have reported a significant difference in age, duration, and VASI score between patients with vitiligo+COVID-19 and those with vitiligo only, there are also studies that have reported conflicting results. For example, a study by Li et al found no significant difference in age, duration, or VASI score between COVID-19 patients with vitiligo and those without vitiligo [ 23 ]. Similarly, a study by Christensen et al reported no significant difference in the prevalence of vitiligo between COVID-19 patients and the general population [ 24 ].…”

Section: Discussionmentioning

confidence: 99%

Post-COVID pigment loss: the connection between vitiligo and the pandemic

Dhaiban,

Abduljabbar Alfadagh,

Jasim

2024

pdia

View full text Add to dashboard Cite

Introduction Vitiligo is an acquired disorder characterized by the progressive loss of functional melanocytes, resulting in depigmented macules and patches on the skin. It affects a significant portion of the world’s population, with no specific gender or geographic predilection. Aim To explore the current understanding of the association between vitiligo and COVID-19. Material and methods This is a cross-sectional comparative research of 90 vitiligo patients, separated into two groups: those with COVID-19 confirmed by PCR and those without, gathered in 2018 before the pandemic. Al-Sadar teaching hospital in Al Basra gathered data from March 2021 to May 2022. Vitiligo patients with other infections were excluded. Wood’s test was used to confirm vitiligo (VASI score). Age, gender, site of vitiligo, number of lesions, and family history were gathered for all patients in both groups. Results Patients with vitiligo and COVID-19 had mild (70.27%), moderate (18.92%), and severe (10.81%) infections. Significant differences were found in age, duration, and VASI score, with younger patients and lower VASI scores in the Vitiligo + COVID-19 group. Females (60.6%) were more affected, and lower limbs (66.7%) were the most common site of vitiligo lesions in COVID-19 patients. Conclusions 70.27% of vitiligo and COVID-19 patients had mild infections, 18.92% had moderate infections, and 10.81% had severe infections. Patients with both disorders were younger, had shorter vitiligo durations, and lower VASI scores than those with just one. Females were more likely to have both disorders, and lower limb vitiligo was more prevalent. Family history did not affect either group.

show abstract

Section: Discussionmentioning

confidence: 99%

Post-COVID pigment loss: the connection between vitiligo and the pandemic

Dhaiban,

Abduljabbar Alfadagh,

Jasim

2024

pdia

View full text Add to dashboard Cite

show abstract

“…Cutaneous lesions associated with SARS-CoV-2 infection are commonly observed in clinical practice, with their prevalence estimated to be around 6% [ 12 ]. Although no formal classification has yet been established, the cutaneous manifestations associated with SARS-CoV-2 infection can generally be categorised into six groups (Table 2 ) [ 13 ].…”

Section: Discussionmentioning

confidence: 99%

A Grover-Like Skin Rash: A Potential Indicator of Underlying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Mihelcic,

Furlan,

Alhameedi

et al. 2024

Cureus

View full text Add to dashboard Cite

Transient acantholytic dermatosis, also known as Grover’s disease, is an acquired dermatological condition characterised by the sudden emergence of pruritic, erythematous papules, or vesicles, primarily affecting the trunk. It is observed most commonly in men older than 50 years. Histology typically demonstrates a pattern of focal acantholysis within the epidermis, dyskeratotic cells including corps ronds and grains, and a variable perivascular lymphocytic infiltrate in the upper dermis. While its aetiology is not well understood, recognised triggers include excessive heat, sweating, sun exposure, and certain drugs, such as chemotherapy agents. More recently, isolated reports of Grover's disease and Grover-like skin eruptions have been described in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and following COVID-19 vaccination. We report the case of a 65-year-old man who presented to secondary care with a nine-day history of an intensely pruritic rash over his chest and back. On internal medical workup, he was found to have SARS-CoV-2 infection and rapidly deteriorated due to coronavirus disease 2019 (COVID-19)-associated pneumonia, necessitating a 10-day hospital admission for supportive care. Diagnostic workup of his skin lesions confirmed transient acantholytic dermatosis (Grover's disease), which resolved following a course of oral corticosteroids. This case underscores the rare but significant association between Grover's disease and COVID-19, contributing valuable insights to the evolving body of literature on cutaneous lesions associated with SARS-CoV-2 infection, and highlighting the importance of considering SARS-CoV-2 screening as part of the diagnostic workup for patients presenting with Grover-like skin eruptions.

show abstract

“…Li et al [34] in their MA estimated a pooled prevalence of cutaneous manifestations of 5.6% (95% CI: 0.040-0.076), with the prevalence of detailed types as follows: maculopapular rash 2%, livedoid lesions 1.4%, petechial lesions 1.1%, urticaria 0.8%, pernio-like lesions 0.5%, vesicular lesions 0.3%.…”

Section: Frequency Of Signsmentioning

confidence: 99%

Epidemiology of Covid-19

Aho¹

2023

Preprint

View full text Add to dashboard Cite

We provide a summary of various epidemiological parameters related to COVID-19 such as incubation period, serial interval and other parameters. Understanding these parameters is important for developing prevention strategies. SARS-CoV-2 can be transmitted by droplets and close contact, but there is evidence of airborne transmission. Aerosol-generating procedures have been identified as one of the specific risk factors for healthcare workers. Super-spreading events refer to situations where a small number of individuals cause the majority of infections. The basic reproductive number (R0) and the spread parameter (k) are used to characterise the transmissibility of the disease. Estimated values for R0 range from 2 to 3 and the estimated value for k is 0.1.The duration of infectiousness depends on viral load and shedding. Viral load varies according to factors such as clinical spectrum, type of variant and vaccination status. The relationship between viral load and infectivity is not fully understood.With regard to the frequency of symptoms and signs of COVID-19, fever, cough, fatigue and dyspnoea are common. The prevalence of olfactory and gustatory dysfunction (OGD) varies between studies and countries. Age and comorbidities are factors associated with olfactory dysfunction.Estimates of the proportion of asymptomatic patients range from 6% to 96%. Asymptomatic transmission is considered likely and is important for control measures.We reviewed the quantitative semiology of COVID-19 is reported on sensitivity, specificity and likelihood ratios of signs.Finally, we also review risk factors for COVID-19 (including health care workers), co-infections, and epidemiology of variants..

show abstract

Prevalence of cutaneous manifestations in COVID‐19: A meta‐analysis

Cited by 6 publications

References 68 publications

Post-COVID pigment loss: the connection between vitiligo and the pandemic

Post-COVID pigment loss: the connection between vitiligo and the pandemic

A Grover-Like Skin Rash: A Potential Indicator of Underlying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Epidemiology of Covid-19

Contact Info

Product

Resources

About